United Patients Group

OCTOBER 25, 2023

From understanding the legality of medical marijuana to its efficacy in treating various medical conditions, our guide will equip you with essential knowledge and insights on this increasingly popular treatment option. Virgin Islands permitting its use for certain medical conditions. What Conditions Can Medical Marijuana Treat?

Marijuana 91

Marijuana Patients Research and Development Edibles 91

Healer

JUNE 20, 2023

  The Healer Cannabis and Dementia webinar includes the latest research and case studies of patients successfully using cannabis and hemp to help with dementia challenges such as agitation, wandering, aggressive behaviors, poor nutrition, pain, sleep and even cognitive abilities.

Research and Development 98

Research and Development Sleep Topical Hemp 98

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

NOVEMBER 9, 2023

Traditional treatments for these conditions often involve medication, physical therapy, or more invasive interventions like surgery. This exciting development could have profound implications for how we approach managing this type of pain. Always consult a physician before making any decision on the treatment of a medical condition.

Treatment 109

Treatment Therapy Research and Development THC 109

Cannabis Law Report

DECEMBER 22, 2019

KEY HIGHLIGHTS: NewAge launches its ‘NHANCED Hemp Topical Products in Australia and New Zealand. Unless required by applicable law, NewAge undertakes no obligation to update or revise any forward-looking statements. NHANCED Hemp Topical Products. DENVER, COLORADO, Dec. Tel: 1-949-574-3860. NBEV@GatewayIR.com. Attachments.

Topical 45

Topical Hemp Research and Development Oil 45

Veriheal

DECEMBER 9, 2021

Opponents are likely referencing studies that link mental illness to regular cannabis use, even though those studies have been invalidated by research and do not even revolve around legalization. The relationship between cannabis consumption, mental health, and suicide has been a hot topic for both those for and against cannabis legalization.

Legalization 98

Legalization Research and Development Consumption Recreational 98

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

MMJ Recs

MAY 15, 2024

Anxiety is a mental health disorder that stands as one of the most prevalent and debilitating conditions affecting millions of individuals worldwide. Anxiety disorders encompass a range of conditions characterized by excessive worry, fear, and apprehension. It leads to avoidance behaviors and profound distress in social settings.

Marijuana 52

Marijuana Therapy Treatment Sleep 52

Cannabis Law Report

MARCH 27, 2019

Coyle – JacksonWhite Attorneys at Law. PUBLISHER: CANNABIS LAW REPORT. Marijuana possession, according to the current laws, is not taken lightly in Arizona. The Arizona laws allow for citizens to vote on referendums and have their say on different topics. AUTHOR: Liz S. The limits are set to 2.5

Law 68

Law Decriminalization Recreational Concentrates 68

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. Many individuals are becoming more cautious about the long-term use of prescription pain medications due to concerns about dependency and the risk of developing opioid use disorder.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

MMJ Recs

APRIL 30, 2024

What was once a stigmatized substance is now increasingly recognized for its therapeutic potential in treating various medical conditions. In the United States, medical marijuana cultivation is governed by a patchwork of state laws and regulations. Medical marijuana in the United States has undergone a significant transformation.

Cultivation 52

Cultivation Supply Chain Extraction Marijuana 52

Cannabis Law Report

MARCH 16, 2022

PsyBio Therapeutics to Make Significant Environmental, Social, and Governance (ESG) Commitment to Promote Mental and Neurological Health While Working to Develop State of the Art Technologies, Process Skills and Capabilities in Lesotho and Across Africa. OXFORD, Ohio and COCONUT CREEK, Fla., per SVS.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

Medical marijuana laws have changed dramatically across the country in recent years, and now cannabis pharmaceuticals appear to be the next big leap forward in cannabis law reform. The recent years have seen drastic marijuana law changes in several states. Cannabis Legalization Throughout The Country.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. The dosage and treatment duration may vary depending on the patient’s specific condition and medical history.

THC 98

THC Chronic Pain Treatment Conditions 98

MMJ Recs

MARCH 20, 2024

These facilities provide a diverse selection of cannabis products, including flower, concentrates, edibles, and topicals, sourced from state-licensed cultivators and manufacturers. Recent developments include the expansion of cultivation facilities, processing centers, and dispensaries to meet growing patient demand.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

AUGUST 17, 2021

This growth opportunity-technology report explores innovations and patents in this space and provides more details about notable companies that are making strides in research and development. Key Topics Covered: 1.0 Research Context and Key Findings. Research Scope. Research Methodology. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

United Patients Group

APRIL 3, 2023

Although both are legal under state law, there are currently 29 states with legislation allowing for medical cannabis and the District of Columbia. A doctor can only recommend that you use medical cannabis, but they cannot prescribe it because it’s not legal under federal law.

DEA 52

DEA Patients Conditions Cannabis 52

PrestoDoctor

OCTOBER 11, 2023

For years, the use of cannabis has been a controversial topic. One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Some individuals may have delayed speech development or struggle with expressing their thoughts and emotions effectively.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. . About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. Visit [link].

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

SpeedWeed

AUGUST 27, 2021

An Australian cultivator claims that his growing of cannabis should be allowed for research purposes. . It is a topic familiar with any advocate if not caretaker in every jurisdiction where cannabis is on the edge of becoming legit (and for any purpose). The Fate of Advocate Growers During Legalization.

Cultivation 67

Cultivation Research and Development Hybrid Pharmaceutical 67

Cannabis Law Report

NOVEMBER 17, 2021

With millions of Canadians suffering, we are proud to offer patients another new cannabinoid formulation to help manage their condition and associated symptoms.”. ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Cannabis Law Report

NOVEMBER 30, 2021

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a next-generation life sciences company leading scientific research and development in phyto-therapeutics, is announcing a transition of its Chief Financial Officer (“CFO”) position. About ZYUS Life Sciences Inc.

Research and Development 52

Research and Development Media Cannabinoids Conditions 52

Cannabis Law Report

APRIL 21, 2022

In a small number of cases, veterinarians reported that pets had died due to cannabis poisoning, though the researchers note that other potential causes, such as underlying conditions, could not be ruled out in the study. ” Source: PLOS. ” Source: PLOS. Journal reference: Amissah, R.Q., PLoS ONE.

Pets 52

Pets Research and Development Topical Consumption 52

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

MARCH 15, 2019

PUBLISHER: CANNABIS LAW REPORT. Sano Ti Amo is a topical product based company in Ohio. Karen has over fifteen years of sales experience, helping start-up companies, and product development. . I’ve been developing the cream for years and really wanted to make it perfect. AUTHOR: Chris Nani.

Topical 45

Topical Chronic Pain Research and Development Patients 45

United Patients Group

FEBRUARY 6, 2023

Rick Simpson Oil, or RSO for short ( aka FECO – Full Extract Cannabis Oil ) is a cannabis-based oil developed by Canadian engineer and cannabis activist Rick Simpson. He allegedly was able to improve his health with RSO, a dark, sticky cannabis extract that can be used as a concentrate, edible, or topical.

Oil 52

Oil Extraction Concentrates Cannabinoids 52

Medicinal Marijuana Association

FEBRUARY 11, 2024

Research suggests that cannabis may help alleviate muscle stiffness and improve mobility in MS patients. Topical creams or patches can target specific areas for localized relief without the psychoactive effects. Yes, you can develop a tolerance to cannabis when using it for multiple sclerosis.

Strains 52

Strains Treatment Consumption Research and Development 52

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Most of the data came from five states that list these indications as qualifying conditions for the use of medical cannabis. How to Use the Data.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JANUARY 10, 2022

Some of the health conditions included in other segments are metabolic disorders, arthritis, dermatological conditions, diabetes, cardiovascular diseases, and glaucoma. In 2020, the others segment accounted for the highest share in the market, owing to the increasing utilization of minor cannabinoids for health conditions.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

United Patients Group

APRIL 11, 2023

Physicians with an MD degree have a wide range of career options, including working in hospitals, clinics, private practices, teaching, and research. Master of Public Health [link] MPH programs focus on the prevention of diseases and the promotion of health through research, education, and community outreach.

Education 52

Education Research and Development Therapy Programs 52

Cannabis Law Report

FEBRUARY 1, 2022

With the launch of Zylem™ Softgels, we are pleased to offer patients an additional cannabinoid delivery method to help manage their condition and associated symptoms,” said ZYUS CEO Brent Zettl. New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

Cannabis Law Report

JANUARY 19, 2022

During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Cannabis Law Report

JANUARY 11, 2019

federal law protects the retail sale of hemp-derived CBD. . Our analysis follows: Hemp-derived CBD is no longer a controlled substance under federal law. The FDA’s position on CBD is unsettled and unsupported by law. While the DEA is now officially out of the hemp regulation business, the U.S.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Cannabis Law Report

JULY 24, 2022

According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. Switzerland is a leader in the research and use of psychedelics in psychiatry and is considered an innovation driver in this field. In this documentary series, author Michael Pollan and Co.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Cannabis Law Report

NOVEMBER 26, 2021

“Since our initial meeting with Avaria, we were impressed by their commitment to research, product development, and most importantly, providing customers with products that work,” said Luis Merchan, President and CEO of Flora Growth. Research, development, and manufacturing takes place in Waterloo and Cambridge, Ontario.

Wellness and Beauty 52

Wellness and Beauty Supply Chain Research and Development Events 52

Cannabis Law Report

JUNE 10, 2021

In April 2021 , Willow announced that it has completed a series of studies with its development partner, Signum Biosciences, Inc., Cellular Goods will be the first to bring a range to market in the United Kingdom built on our core principles of delivering efficacy-led and research-backed consumer cannabinoid products.”

Research and Development 66

Research and Development Cannabinoids Pharmaceutical Policy 66

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122